PROTEON THERAPEUTICS INC (41)

Browse by Contract Category

Contracts

Separation Agreement and Release, dated as of October 15, 2021, by and between the Company and Martn Sebastian Olivo, M.D (Filed With SEC on October 18, 2021)
Lease by and between 345 PAS HOLDING LLC, and the Registrant, dated as of December 7, 2020 (Filed With SEC on March 11, 2021)
Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on March 11, 2021)
Underwriting Agreement related to the Common Offering, dated September 22, 2020, among Protara Therapeutics, Inc., Cowen and Company, LLC and Guggenheim Securities, LLC (Filed With SEC on September 23, 2020)
License Agreement, by and between ArTara Subsidiary, Inc. and The Feinstein Institute for Medical Research dated as of December 22, 2017 (Filed With SEC on January 10, 2020)
Amendment No. 1 to Agreement and Plan of Merger and Reorganization, dated November 19, 2019, by and among the Registrant, ArTara Therapeutics, Inc. and REM 1 Acquisition, Inc (Filed With SEC on January 10, 2020)
Consulting Agreement, dated as of October 16, 2021, by and between the Company and Martn Sebastian Olivo, M.D (Filed With SEC on October 18, 2021)
Executive Employment Agreement, effective as of April 19, 2021, by and between the Registrant and Martn Sebastian Olivo, M.D (Filed With SEC on May 6, 2021)
Restated Non-Employee Director Compensation Policy (Filed With SEC on May 6, 2021)
Amendment to Agreement, by and between Chugai Pharmaceutical Co., Ltd. and the Registrant, dated as of July 14, 2020 and effective as of June 30, 2020 (Filed With SEC on November 12, 2020)
Underwriting Agreement related to the Preferred Offering, dated September 22, 2020, among Protara Therapeutics, Inc., Cowen and Company, LLC and Guggenheim Securities, LLC (Filed With SEC on September 23, 2020)
Restated Non-Employee Director Compensation Policy (Filed With SEC on July 31, 2020)
Separation Agreement and Release, dated as of July 23, 2020, by and between the Registrant and Julio Casoy (Filed With SEC on July 31, 2020)
ArTara Therapeutics, Inc. Inducement Plan (Filed With SEC on March 30, 2020)
Form of Stock Option Grant Notice and Stock Option Agreement under ArTara Therapeutics, Inc. Inducement Plan (Filed With SEC on March 30, 2020)
Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under ArTara Therapeutics, Inc. Inducement Plan (Filed With SEC on March 30, 2020)
Executive Employment Agreement, effective as of February 11, 2020 by and between the Registrant and Blaine Davis (Filed With SEC on March 20, 2020)
Restated Non-Employee Director Compensation Policy (Filed With SEC on March 20, 2020)
Executive Employment Agreement, dated as of February 6, 2020, by and between the Registrant and Julio Casoy, M.D (Filed With SEC on March 20, 2020)
Forms of Stock Option Agreement, Option Exercise, Restricted Stock Unit Grant and Restricted Stock Unit Agreement under the Amended and Restated 2014 Equity Incentive Plan of the... (Filed With SEC on March 20, 2020)
Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on March 20, 2020)
Subscription Agreement, dated September 23, 2019, by and among the Registrant and the institutional investors named therein, and the First Amendment to Subscription Agreement,... (Filed With SEC on January 10, 2020)
2017 Equity Incentive Plan of ArTara Subsidiary, Inc (Filed With SEC on January 10, 2020)
Non-Employee Director Compensation Policy (Filed With SEC on January 10, 2020)
Form of Indemnity Agreement between the Registrant and each of its directors and officers (Filed With SEC on January 10, 2020)
Executive Employment Agreement, dated as of November 5, 2019, as amended on December 4, 2019, by and between ArTara Subsidiary, Inc. and Jesse Shefferman (Filed With SEC on January 10, 2020)
Agreement, by and between ArTara Subsidiary, Inc. and Chugai Pharmaceutical Co., Ltd. dated as of June 17, 2019 (Filed With SEC on January 10, 2020)
Amended and Restated 2014 Equity Incentive Plan of the Registrant, as amended (Filed With SEC on January 10, 2020)
Form of Common Stock Certificate (Filed With SEC on January 10, 2020)
Executive Employment Agreement, dated as of December 17, 2019, by and between ArTara Subsidiary, Inc. and Jacqueline Zummo, Ph.D., MPH, MBA (Filed With SEC on January 10, 2020)
Choline License Agreement, by and between ArTara Subsidiary, Inc. and Alan L. Buchman, M.D. dated as of September 27, 2017 (Filed With SEC on January 10, 2020)
Sponsored Research and License Agreement, by and between ArTara Subsidiary, Inc. and The University of Iowa dated as of November 28, 2018 (Filed With SEC on January 10, 2020)
Separation Agreement, dated December 20, 2019, by and between Proteon Therapeutics, Inc. and George A. Eldridge (Filed With SEC on December 23, 2019)
Consulting Agreement, dated October 1, 2019, by and among Proteon Therapeutics, Inc., certain of Proteons subsidiaries and Timothy P. Noyes (Filed With SEC on October 2, 2019)
Separation Agreement, dated September 30, 2019, by and between Proteon Therapeutics, Inc. and Timothy P. Noyes (Filed With SEC on October 2, 2019)
Agreement and Plan of Merger and Reorganization, dated September 23, 2019, by and among Proteon Therapeutics, Inc., REM 1 Acquisition, Inc. and ArTara Therapeutics, Inc (Filed With SEC on September 24, 2019)
Form of Support Agreement, by and among Proteon Therapeutics, Inc., ArTara Therapeutics, Inc. and certain stockholders of Proteon Therapeutics, Inc. named therein (Filed With SEC on September 24, 2019)
Registration Rights Agreement, dated September 23, 2019, by and among Proteon Therapeutics, Inc. and the institutional investors named therein (Filed With SEC on September 24, 2019)
Subscription Agreement, dated September 23, 2019, by and among Proteon Therapeutics, Inc. and the institutional investors named therein (Filed With SEC on September 24, 2019)
Form of Lock-Up Agreement, by each of the parties named in each agreement therein (Filed With SEC on September 24, 2019)
Form of Support Agreement, by and among ArTara Therapeutics, Inc., Proteon Therapeutics, Inc. and certain stockholders of ArTara Therapeutics, Inc. named therein (Filed With SEC on September 24, 2019)